Literature DB >> 10618705

p53 regulation by post-translational modification and nuclear retention in response to diverse stresses.

G S Jimenez1, S H Khan, J M Stommel, G M Wahl.   

Abstract

p53 activation by diverse stresses involves post-translational modifications that alter its structure and result in its nuclear accumulation. We will discuss several unresolved topics regarding p53 regulation which are currently under investigation. DNA damage is perhaps the best-studied stress which activates p53, and recent data implicate phosphorylation at N-terminal serine residues as critical in this process. We discuss recent data regarding the potential kinases which modify p53 and the possible role of the resulting phosphorylation events. By contrast, much less is understood about agents which disrupt the mitotic spindle. The cell cycle phase, induction signal, and biochemical mechanism of the reversible arrest induced by microtubule disruption are currently under investigation. Finally, a key event in response to any genotoxic stress is the accumulation of p53 in the nucleus. The factors which determine the steady state level of p53 are starting to be elucidated, but the mechanisms responsible for nuclear accumulation and nuclear export remain controversial. We discuss new studies revealing a mechanism for nuclear retention of p53, and the potential contributions of MDM2 to this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10618705     DOI: 10.1038/sj.onc.1203013

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  Cell apoptosis induced by carcinogenic metals.

Authors:  F Chen; V Vallyathan; V Castranova; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

Review 2.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 3.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis.

Authors:  R Benetti; G Del Sal; M Monte; G Paroni; C Brancolini; C Schneider
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

6.  Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.

Authors:  Shih-Shun Chen; Pi-Chu Chang; Yu-Wen Cheng; Fen-Mei Tang; Young-Sun Lin
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

7.  Flexible lid to the p53-binding domain of human Mdm2: implications for p53 regulation.

Authors:  Mark A McCoy; Jennifer J Gesell; Mary M Senior; Daniel F Wyss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

8.  PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy.

Authors:  Samisubbu R Naidu; Alexander J Lakhter; Elliot J Androphy
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

9.  Cloning and characterization of the human gene DERP6, which activates transcriptional activities of p53.

Authors:  Jian Yuan; Wenwen Tang; Kuntian Luo; Xinya Chen; Xiuting Gu; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2006-09       Impact factor: 2.316

10.  Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.

Authors:  Ayako Suzuki; Masatoshi Kariya; Noriomi Matsumura; Tsukasa Baba; Haruhiko Yagi; Masaki Mandai; Ikuo Konishi; Shingo Fujii
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.